Citi Downgrades NGM Biopharmaceuticals (NGM) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Form SC 13D/A NGM BIOPHARMACEUTICALS Filed by: COLUMN GROUP L P
February 26, 2024 5:16 PM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
... MoreForm SC14D9C NGM BIOPHARMACEUTICALS Filed by: NGM BIOPHARMACEUTICALS INC
February 26, 2024 5:12 PM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
... MoreForm 8-K NGM BIOPHARMACEUTICALS For: Feb 25
February 26, 2024 5:02 PM ESTNGM BIOPHARMACEUTICALS INC false 0001426332 0001426332... More
Form SC TO-C NGM BIOPHARMACEUTICALS Filed by: COLUMN GROUP L P
February 26, 2024 4:56 PM EST
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.... More
